Does promethazine shorten the length of stay in the post anesthesia care unit?. Issue 7 (July 2018)

• Record Type: Journal Article
• Authors: Eskander, Jonathan P.; Rapoport, Yury; Cornett, Elyse; Gennuso, Sonja; Franklin, Michael; Kaye, Alan D.; Fox, Charles J.
• Is Part Of: Journal of perioperative practice. Volume 28:Issue 7/8(2018)
• Page Start: 194
• Page End: 198
• Publication Date: 2018-07
• Subjects: Promethazine -- PACU -- Pain -- Post anesthesia care unit -- Opioid -- Hydromorphone -- Morphine -- Total abdominal hysterectomy -- TAH -- Length of stay -- LOS -- Nausea -- Vomiting; Operating room nursing -- Periodicals; 617.9192
• DOI: 10.1177/1750458918776548
• Languages: English
• ISSNs: 2515-7949

Abstract

The combination of promethazine and opioids is known to have an opioid-sparing effect, thereby facilitating a reduction in total patient opioid consumption. In recent years, this practice has fallen out of favor in many healthcare facilities, except primarily in the post anesthesia care unit (PACU). The goal of this study was to highlight the potential of promethazine as a direct or indirect adjuvant medication in acute pain management. The present investigation was undertaken with a case series of adult female patients who underwent open total abdominal hysterectomies. Data from the PACU was reviewed with patients being separated into two groups. Group 1 received only intravenous opioids for acute pain management. Group 2 received a combination of intravenous opioids for acute pain management and intravenous promethazine for nausea and/or vomiting. Patients were discharged from the PACU with a modified Aldrete score of 9 or 10. The study showed that patients who received promethazine in addition to opioids were discharged from the PACU an average of 19.2 minutes earlier than those patients who received only opioids (p=0.003). The time to achieve modified Aldrete score of 9 or higher was more quickly achieved when open abdominal hysterectomy patients received promethazine in addition to opioids in the PACU. The study concluded that promethazine, in combination with opioids, could potentially decrease PACU stay postoperatively. Based on the present investigation, the prospect of using promethazine in other facets of pain management are intriguing and warrant future studies. Specifically, it may be worth investigating whether promethazine is truly an adjunct in combination with opioids and to determine if there are any other antihistamines or neuroleptics which may have similar clinical effects to promethazine.